AMPD2 is the liver-type ("L") isoform of AMP deaminase, one of three mammalian AMP deaminase paralogs (with muscle-type AMPD1 and erythrocyte-type AMPD3). It is broadly expressed, including in brain and neurons, and is highly expressed in cerebellum. AMPD2 is a cytosolic, zinc-dependent metalloenzyme (binds one Zn2+ per subunit; assembles as a homotetramer) that catalyzes the hydrolytic deamination of AMP to IMP plus ammonia (AMP + H2O + H+ = IMP + NH4+; EC 3.5.4.6). This reaction is the committed entry step of the purine nucleotide cycle and a key point of AMP catabolism, so AMPD2 helps set the cellular adenylate energy charge (AMP/ADP/ATP ratio) and shapes adenine and guanine nucleotide pools. By lowering AMP/adenosine- derived nucleotides, AMPD2 relieves feedback inhibition of de novo purine synthesis and thereby sustains the guanine nucleotide (GTP) pool; this is especially important in neurons and neural progenitors, where GTP is required for translation initiation. Loss-of-function mutations cause severe recessive neurodevelopmental/neurodegenerative disease, including pontocerebellar hypoplasia type 9 (PCH9) and a form of hereditary spastic paraplegia (SPG63); the cellular defect can be partially rescued by purine precursor supplementation.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0003876
AMP deaminase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Core molecular function of AMPD2: hydrolytic deamination of AMP to IMP + ammonia. This phylogenetically-inferred MF is the well-established, experimentally supported activity of the enzyme and represents the core function of the gene.
Reason: AMP deaminase activity is the defining function of AMPD2, confirmed biochemically (patient-cell AMP deaminase assays) and by yeast complementation, and captured by UniProt catalytic activity (EC 3.5.4.6). The IBA is at the correct level of specificity.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Catalyzes the deamination of AMP to IMP and plays an important role in
PMID:23911318
which converts AMP to IMP
|
|
GO:0006188
IMP biosynthetic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IMP is the direct product of the AMP deaminase reaction; UniProt frames this as "IMP biosynthesis via salvage pathway; IMP from AMP: step 1/1". The phylogenetic inference is appropriate and reflects the immediate metabolic role of the enzyme.
Reason: Producing IMP from AMP is exactly what AMPD2 does, so this process annotation is well supported and consistent with the pathway assignment in UniProt.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Purine metabolism; IMP biosynthesis via salvage pathway; IMP
|
|
GO:0046033
AMP metabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: AMPD2 consumes AMP (deaminating it to IMP), placing it squarely in AMP metabolism. This higher-level process term is the natural container for the reaction and is a core process for the gene.
Reason: Directly supported by the catalyzed reaction (AMP is the substrate). Correct and not over-annotated.
Supporting Evidence:
PMID:23911318
AMPD2 executes AMP deamination
|
|
GO:0003876
AMP deaminase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic assertion (ARBA/RHEA/EC 3.5.4.6/InterPro AMPD family) of the same core AMP deaminase activity. Redundant with the IBA/IGI/NAS annotations but correct.
Reason: The InterPro/EC/RHEA mapping to AMP deaminase activity is accurate for AMPD2.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Reaction=AMP + H2O + H(+) = IMP + NH4(+)
|
|
GO:0006188
IMP biosynthetic process
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: ARBA electronic annotation of IMP biosynthetic process, consistent with production of IMP from AMP. Redundant with the IBA/IGI evidence but correct.
Reason: IMP is the reaction product; the process assignment is appropriate.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Purine metabolism; IMP biosynthesis via salvage pathway; IMP
|
|
GO:0009168
purine ribonucleoside monophosphate biosynthetic process
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro2GO mapping to a parent process term (IMP is a purine ribonucleoside monophosphate). Broader than the specific IMP biosynthetic process term but not wrong for this enzyme.
Reason: IMP, the product of AMPD2, is a purine ribonucleoside monophosphate, so this higher-level biosynthetic term is consistent. It is more general than GO:0006188 and is retained as non-core context rather than the primary process term.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Purine metabolism; IMP biosynthesis via salvage pathway; IMP
|
|
GO:0019239
deaminase activity
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: InterPro2GO mapping to the generic parent "deaminase activity". The specific and informative child term GO:0003876 (AMP deaminase activity) is already annotated, making this general term uninformative.
Reason: Too general; the precise activity (AMP deaminase activity, GO:0003876) is already captured by multiple annotations. Retaining the generic parent adds no information.
Proposed replacements:
AMP deaminase activity
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Catalyzes the deamination of AMP to IMP and plays an important role in
|
|
GO:0032264
IMP salvage
|
IEA
GO_REF:0000120 |
KEEP AS NON CORE |
Summary: UniPathway-derived electronic annotation. UniProt assigns AMP->IMP deamination to the "IMP biosynthesis via salvage pathway" (UPA00591), so IMP salvage is a reasonable process context for AMPD2.
Reason: Consistent with the UniProt/UniPathway framing of the AMP->IMP step as part of IMP salvage. Retained as non-core process context alongside the more direct AMP/IMP metabolic terms.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Purine metabolism; IMP biosynthesis via salvage pathway; IMP
|
|
GO:0097009
energy homeostasis
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: AMP deaminase sets the cellular adenylate energy charge by regulating AMP levels, linking it to energy homeostasis. Supported by the primary literature framing of purine metabolism as essential for energy homeostasis.
Reason: A valid higher-level physiological role that is downstream of the catalytic function rather than the core molecular activity itself; retained as non-core.
Supporting Evidence:
PMID:23911318
essential for cellular energy homeostasis and nucleic acid synthesis
|
|
GO:0106380
purine ribonucleotide salvage
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: ARBA electronic annotation placing AMPD2 in purine ribonucleotide salvage, consistent with the UniProt/UniPathway assignment of the AMP->IMP step to IMP salvage.
Reason: Compatible with the salvage-pathway framing of the AMP->IMP reaction. Broad process context; retained as non-core.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Purine metabolism; IMP biosynthesis via salvage pathway; IMP
|
|
GO:0005515
protein binding
|
IPI
PMID:21044950 Genome-wide YFP fluorescence complementation screen identifi... |
MARK AS OVER ANNOTATED |
Summary: IntAct IPI capturing a binary interaction with TERF1 (P54274) detected in a genome-wide fluorescence-complementation telomere-signaling screen. "protein binding" is uninformative and no functional module for AMPD2 is established by this.
Reason: Per curation guidance, bare protein binding (GO:0005515) is uninformative; this is a high-throughput interaction from a telomere-signaling screen with no evidence that it reflects a physiological AMPD2 function. Not removed (experimental IPI), but marked as over-annotated.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Q01433; P54274: TERF1
|
|
GO:0005515
protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
MARK AS OVER ANNOTATED |
Summary: IntAct IPI capturing a binary interaction with CCNDBP1 (O95273) from a proteome-scale human interactome map (yeast two-hybrid). Uninformative bare protein binding.
Reason: High-throughput interactome interaction; "protein binding" gives no functional insight and no AMPD2-specific module is established. Retained (experimental IPI) but marked over-annotated.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Q01433; O95273: CCNDBP1
|
|
GO:0005515
protein binding
|
IPI
PMID:31515488 Extensive disruption of protein interactions by genetic vari... |
MARK AS OVER ANNOTATED |
Summary: IntAct IPI, again reporting an interaction involving CCNDBP1 (O95273), from a study of variant-mediated disruption of protein interactions. Uninformative bare protein binding.
Reason: High-throughput interaction; "protein binding" is uninformative and no functional module is established. Retained (experimental IPI) but marked over-annotated.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Q01433; O95273: CCNDBP1
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: IntAct IPI reporting an interaction with HIRIP3 (Q9BW71) from a dual proteome-scale interactome (BioPlex) study. Uninformative bare protein binding.
Reason: High-throughput interaction; "protein binding" is uninformative and no functional module is established. Retained (experimental IPI) but marked over-annotated.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Q01433; Q9BW71: HIRIP3
|
|
GO:0005515
protein binding
|
IPI
PMID:34819669 A multi-scale map of cell structure fusing protein images an... |
MARK AS OVER ANNOTATED |
Summary: IntAct IPI reporting an interaction with HIRIP3 (Q9BW71) from a multi-scale cell-structure map (AP-MS/imaging). Uninformative bare protein binding.
Reason: High-throughput interaction; "protein binding" is uninformative and no functional module is established. Retained (experimental IPI) but marked over-annotated.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Q01433; Q9BW71: HIRIP3
|
|
GO:0005515
protein binding
|
IPI
PMID:40205054 Multimodal cell maps as a foundation for structural and func... |
MARK AS OVER ANNOTATED |
Summary: IntAct IPI reporting an interaction with HIRIP3 (Q9BW71) from a multimodal cell-map study. Uninformative bare protein binding.
Reason: High-throughput interaction; "protein binding" is uninformative and no functional module is established. Retained (experimental IPI) but marked over-annotated.
Supporting Evidence:
file:human/AMPD2/AMPD2-uniprot.txt
Q01433; Q9BW71: HIRIP3
|
|
GO:0046033
AMP metabolic process
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Ensembl orthology-based electronic transfer (from mouse Ampd2, Q9DBT5) of AMP metabolic process. Correct, and redundant with the IBA annotation of the same term.
Reason: AMP is the substrate of AMPD2; this is a correct core process annotation.
Supporting Evidence:
PMID:23911318
AMPD2 executes AMP deamination
|
|
GO:0046034
ATP metabolic process
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Ensembl orthology-based electronic annotation (from mouse Q9DBT5). AMPD2 loss elevates ATP levels, so its activity indirectly influences ATP/adenylate pools, but ATP is neither substrate nor product of the deaminase reaction.
Reason: Biologically supported as an indirect/regulatory effect (AMPD2-deficient cells accumulate ATP), not the direct catalyzed reaction. Retained as non-core.
Supporting Evidence:
PMID:23911318
elevated ATP levels, more striking in AMPD2 homozygous mutant cells
|
|
GO:0046039
GTP metabolic process
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Ensembl orthology-based electronic annotation (from mouse Q9DBT5). AMPD2 activity is required to sustain the guanine nucleotide (GTP) pool by relieving feedback inhibition of de novo purine synthesis; AMPD2 loss depletes GTP. This is an indirect/regulatory role rather than the direct catalyzed reaction.
Reason: Strongly supported biologically as a downstream consequence of AMPD2 activity (GTP halved in patient neural progenitors), but AMPD2 does not directly metabolize GTP. Retained as an important non-core process.
Supporting Evidence:
PMID:23911318
dramatic reduction in guanine nucleotides, most remarkable for GTP, which was reduced by half
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-76590 |
ACCEPT |
Summary: Cytosolic localization of AMP deaminase, asserted by Reactome. Consistent with the known subcellular distribution of the enzyme.
Reason: AMPD is a cytosolic enzyme; the localization is well established and appropriate as the core cellular component.
Supporting Evidence:
Reactome:R-HSA-76590
Cytosolic AMP deaminase (AMPD) catalyzes the hydrolysis of AMP to yield IMP and ammonia
|
|
GO:0032263
GMP salvage
|
IDA
PMID:29079593 Hypoxia modulates the purine salvage pathway and decreases r... |
MARK AS OVER ANNOTATED |
Summary: MGI IDA to GMP salvage citing a red-blood-cell purine-metabolism study. That study centers on the erythrocyte AMPD isoform (AMPD3) and the RBC purine salvage/deamination network; it does not establish AMPD2 specifically in GMP salvage, and mechanistically AMP deaminase produces IMP (not GMP).
Reason: The term is a poor fit for AMP deaminase (which acts on AMP->IMP, upstream of, but not within, GMP salvage), and the cited paper foregrounds the erythrocyte AMPD3 isoform and the salvage network generally. Per curation policy this experimental annotation is not removed; the loose acts_upstream_of_or_within qualifier is retained but marked as an over-annotation for AMPD2.
Supporting Evidence:
PMID:29079593
enhanced purine salvage reactions in human and mouse red blood cells
|
|
GO:0052652
cyclic purine nucleotide metabolic process
|
IMP
PMID:23911318 AMPD2 regulates GTP synthesis and is mutated in a potentiall... |
MARK AS OVER ANNOTATED |
Summary: IMP annotation from the AMPD2/PCH9 study. That work demonstrates AMPD2's role in purine (AMP/IMP/GTP) nucleotide metabolism and guanine-nucleotide homeostasis, not in cyclic nucleotide (cAMP/cGMP) metabolism specifically, so the chosen term is a mismatch to the experimental readouts.
Reason: The phenotype (guanine/adenine nucleotide pool changes, translation initiation defect) supports purine-nucleotide metabolic terms rather than "cyclic purine nucleotide metabolic process". Experimental annotation, so not removed; marked over-annotated as the AMP/IMP/purine metabolic process terms better capture the finding.
Proposed replacements:
AMP metabolic process
Supporting Evidence:
PMID:23911318
we identify AMPD2 as necessary for guanine nucleotide biosynthesis and protein translation
|
|
GO:0003876
AMP deaminase activity
|
IGI
PMID:23911318 AMPD2 regulates GTP synthesis and is mutated in a potentiall... |
ACCEPT |
Summary: Experimental (IGI) support for AMP deaminase activity: human AMPD2 functionally complements the yeast amd1 (AMP deaminase) mutant, and patient cells lacking AMPD2 lose 80-90% of AMP deaminase activity. Core molecular function.
Reason: Directly demonstrates AMP deaminase activity for AMPD2 via cross-species genetic interaction/complementation and enzymatic assay of patient cells. This is the core function.
Supporting Evidence:
PMID:23911318
which converts AMP to IMP
|
|
GO:0006188
IMP biosynthetic process
|
IGI
PMID:23911318 AMPD2 regulates GTP synthesis and is mutated in a potentiall... |
ACCEPT |
Summary: Experimental (IGI, yeast amd1 complementation) support that AMPD2 acts in production of IMP from AMP. Consistent with the core metabolic role of the enzyme.
Reason: Supported by functional complementation and by the direct chemistry of the reaction (AMP->IMP). Correct process for the gene.
Supporting Evidence:
PMID:23911318
which converts AMP to IMP
|
|
GO:0097009
energy homeostasis
|
IGI
PMID:23911318 AMPD2 regulates GTP synthesis and is mutated in a potentiall... |
KEEP AS NON CORE |
Summary: Experimental (IGI) support linking AMPD2 to cellular energy/purine homeostasis via the yeast amd1 complementation system and the demonstrated regulation of adenine/guanine nucleotide pools. A valid higher-level physiological role.
Reason: Downstream physiological role (setting the adenylate energy charge / purine pools) rather than the direct catalytic activity; retained as non-core.
Supporting Evidence:
PMID:23911318
essential for cellular energy homeostasis and nucleic acid synthesis
|
|
GO:0003876
AMP deaminase activity
|
NAS
PMID:8764830 Cloning, sequence and characterization of the human AMPD2 ge... |
ACCEPT |
Summary: Author statement (NAS) of AMP deaminase activity from the AMPD2 gene cloning and characterization paper, which describes AMPD2 as a member of the AMP deaminase multigene family. Same core function as the IBA/IGI/IEA annotations.
Reason: Correct core molecular function; the cloning paper explicitly identifies AMPD2 as an AMP deaminase family gene. Redundant with stronger experimental evidence but accurate.
Supporting Evidence:
PMID:8764830
AMP deaminase (AMPD) is manifest through a multigene family in higher
|
|
GO:0006196
AMP catabolic process
|
IDA
PMID:23911318 AMPD2 regulates GTP synthesis and is mutated in a potentiall... |
NEW |
Summary: Proposed annotation for the most precise process term describing the AMPD2 reaction: catabolic breakdown of AMP (AMP -> IMP + ammonia). Directly supported by the demonstrated AMP deaminase activity and loss of that activity in patient cells.
Reason: The AMP->IMP deamination is a breakdown of AMP and is best captured by AMP catabolic process. Existing annotations use the broader parent (AMP metabolic process, GO:0046033) and product-oriented terms (IMP biosynthetic process); adding the specific catabolic term makes the substrate-consuming role explicit. Supported experimentally.
Supporting Evidence:
PMID:23911318
which converts AMP to IMP
file:human/AMPD2/AMPD2-uniprot.txt
Catalyzes the deamination of AMP to IMP and plays an important role in
|
Q: Do the four AMPD2 splice isoforms (differing mainly in N-terminal extension) differ in catalytic regulation, subcellular targeting, or tissue distribution?
Q: In post-mitotic neurons, where de novo purine synthesis is low, what is the precise mechanism by which AMPD2 loss depletes GTP and impairs translation initiation?
Experiment: Isoform-resolved enzyme kinetics and allosteric regulation (by ATP, GTP, phosphate) of the four AMPD2 splice variants expressed and purified in parallel.
Experiment: Metabolic-flux (labeled-adenosine) analysis in AMPD2-null vs rescued human neurons to map how the AMP->IMP block redistributes purine flux toward or away from the guanine branch.
UniProtKB: Q01433 (AMPD2_HUMAN). HGNC:469. Human, NCBITaxon:9606.
Deep research: falcon provider was OUT OF CREDITS (HTTP 402); no -deep-research-falcon.md generated.
This review is grounded in the cached UniProt record, the seeded GOA, and cached publications.
id: Q01433
gene_symbol: AMPD2
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
AMPD2 is the liver-type ("L") isoform of AMP deaminase, one of three mammalian
AMP deaminase paralogs (with muscle-type AMPD1 and erythrocyte-type AMPD3).
It is broadly expressed, including in brain and neurons, and is highly expressed
in cerebellum. AMPD2 is a cytosolic, zinc-dependent metalloenzyme (binds one Zn2+
per subunit; assembles as a homotetramer) that catalyzes the hydrolytic deamination
of AMP to IMP plus ammonia (AMP + H2O + H+ = IMP + NH4+; EC 3.5.4.6). This reaction
is the committed entry step of the purine nucleotide cycle and a key point of AMP
catabolism, so AMPD2 helps set the cellular adenylate energy charge (AMP/ADP/ATP
ratio) and shapes adenine and guanine nucleotide pools. By lowering AMP/adenosine-
derived nucleotides, AMPD2 relieves feedback inhibition of de novo purine synthesis
and thereby sustains the guanine nucleotide (GTP) pool; this is especially important
in neurons and neural progenitors, where GTP is required for translation initiation.
Loss-of-function mutations cause severe recessive neurodevelopmental/neurodegenerative
disease, including pontocerebellar hypoplasia type 9 (PCH9) and a form of hereditary
spastic paraplegia (SPG63); the cellular defect can be partially rescued by purine
precursor supplementation.
alternative_products:
- name: Ex1B-2-3
id: Q01433-1
- name: Ex1A-2-3
id: Q01433-2
sequence_note: VSP_001271, VSP_001272
- name: Ex1B-3
id: Q01433-4
sequence_note: VSP_001273
- name: '5'
id: Q01433-5
sequence_note: VSP_045975
existing_annotations:
- term:
id: GO:0003876
label: AMP deaminase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Core molecular function of AMPD2: hydrolytic deamination of AMP to IMP + ammonia.
This phylogenetically-inferred MF is the well-established, experimentally supported
activity of the enzyme and represents the core function of the gene.
action: ACCEPT
reason: >-
AMP deaminase activity is the defining function of AMPD2, confirmed biochemically
(patient-cell AMP deaminase assays) and by yeast complementation, and captured by
UniProt catalytic activity (EC 3.5.4.6). The IBA is at the correct level of specificity.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Catalyzes the deamination of AMP to IMP and plays an important role in"
- reference_id: PMID:23911318
supporting_text: which converts AMP to IMP
- term:
id: GO:0006188
label: IMP biosynthetic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
IMP is the direct product of the AMP deaminase reaction; UniProt frames this as
"IMP biosynthesis via salvage pathway; IMP from AMP: step 1/1". The phylogenetic
inference is appropriate and reflects the immediate metabolic role of the enzyme.
action: ACCEPT
reason: >-
Producing IMP from AMP is exactly what AMPD2 does, so this process annotation is
well supported and consistent with the pathway assignment in UniProt.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Purine metabolism; IMP biosynthesis via salvage pathway; IMP"
- term:
id: GO:0046033
label: AMP metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
AMPD2 consumes AMP (deaminating it to IMP), placing it squarely in AMP metabolism.
This higher-level process term is the natural container for the reaction and is a
core process for the gene.
action: ACCEPT
reason: >-
Directly supported by the catalyzed reaction (AMP is the substrate). Correct and
not over-annotated.
supported_by:
- reference_id: PMID:23911318
supporting_text: AMPD2 executes AMP deamination
- term:
id: GO:0003876
label: AMP deaminase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic assertion (ARBA/RHEA/EC 3.5.4.6/InterPro AMPD family) of the same core
AMP deaminase activity. Redundant with the IBA/IGI/NAS annotations but correct.
action: ACCEPT
reason: >-
The InterPro/EC/RHEA mapping to AMP deaminase activity is accurate for AMPD2.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Reaction=AMP + H2O + H(+) = IMP + NH4(+)"
- term:
id: GO:0006188
label: IMP biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
ARBA electronic annotation of IMP biosynthetic process, consistent with production
of IMP from AMP. Redundant with the IBA/IGI evidence but correct.
action: ACCEPT
reason: >-
IMP is the reaction product; the process assignment is appropriate.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Purine metabolism; IMP biosynthesis via salvage pathway; IMP"
- term:
id: GO:0009168
label: purine ribonucleoside monophosphate biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro2GO mapping to a parent process term (IMP is a purine ribonucleoside
monophosphate). Broader than the specific IMP biosynthetic process term but not
wrong for this enzyme.
action: KEEP_AS_NON_CORE
reason: >-
IMP, the product of AMPD2, is a purine ribonucleoside monophosphate, so this
higher-level biosynthetic term is consistent. It is more general than GO:0006188
and is retained as non-core context rather than the primary process term.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Purine metabolism; IMP biosynthesis via salvage pathway; IMP"
- term:
id: GO:0019239
label: deaminase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro2GO mapping to the generic parent "deaminase activity". The specific and
informative child term GO:0003876 (AMP deaminase activity) is already annotated,
making this general term uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Too general; the precise activity (AMP deaminase activity, GO:0003876) is already
captured by multiple annotations. Retaining the generic parent adds no information.
proposed_replacement_terms:
- id: GO:0003876
label: AMP deaminase activity
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Catalyzes the deamination of AMP to IMP and plays an important role in"
- term:
id: GO:0032264
label: IMP salvage
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: >-
UniPathway-derived electronic annotation. UniProt assigns AMP->IMP deamination to
the "IMP biosynthesis via salvage pathway" (UPA00591), so IMP salvage is a
reasonable process context for AMPD2.
action: KEEP_AS_NON_CORE
reason: >-
Consistent with the UniProt/UniPathway framing of the AMP->IMP step as part of IMP
salvage. Retained as non-core process context alongside the more direct AMP/IMP
metabolic terms.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Purine metabolism; IMP biosynthesis via salvage pathway; IMP"
- term:
id: GO:0097009
label: energy homeostasis
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
AMP deaminase sets the cellular adenylate energy charge by regulating AMP levels,
linking it to energy homeostasis. Supported by the primary literature framing of
purine metabolism as essential for energy homeostasis.
action: KEEP_AS_NON_CORE
reason: >-
A valid higher-level physiological role that is downstream of the catalytic function
rather than the core molecular activity itself; retained as non-core.
supported_by:
- reference_id: PMID:23911318
supporting_text: essential for cellular energy homeostasis and nucleic acid synthesis
- term:
id: GO:0106380
label: purine ribonucleotide salvage
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
ARBA electronic annotation placing AMPD2 in purine ribonucleotide salvage, consistent
with the UniProt/UniPathway assignment of the AMP->IMP step to IMP salvage.
action: KEEP_AS_NON_CORE
reason: >-
Compatible with the salvage-pathway framing of the AMP->IMP reaction. Broad process
context; retained as non-core.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Purine metabolism; IMP biosynthesis via salvage pathway; IMP"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:21044950
qualifier: enables
review:
summary: >-
IntAct IPI capturing a binary interaction with TERF1 (P54274) detected in a
genome-wide fluorescence-complementation telomere-signaling screen. "protein binding"
is uninformative and no functional module for AMPD2 is established by this.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Per curation guidance, bare protein binding (GO:0005515) is uninformative; this is a
high-throughput interaction from a telomere-signaling screen with no evidence that it
reflects a physiological AMPD2 function. Not removed (experimental IPI), but marked as
over-annotated.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Q01433; P54274: TERF1"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
qualifier: enables
review:
summary: >-
IntAct IPI capturing a binary interaction with CCNDBP1 (O95273) from a proteome-scale
human interactome map (yeast two-hybrid). Uninformative bare protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: >-
High-throughput interactome interaction; "protein binding" gives no functional insight
and no AMPD2-specific module is established. Retained (experimental IPI) but marked
over-annotated.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Q01433; O95273: CCNDBP1"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:31515488
qualifier: enables
review:
summary: >-
IntAct IPI, again reporting an interaction involving CCNDBP1 (O95273), from a study of
variant-mediated disruption of protein interactions. Uninformative bare protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: >-
High-throughput interaction; "protein binding" is uninformative and no functional
module is established. Retained (experimental IPI) but marked over-annotated.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Q01433; O95273: CCNDBP1"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
IntAct IPI reporting an interaction with HIRIP3 (Q9BW71) from a dual proteome-scale
interactome (BioPlex) study. Uninformative bare protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: >-
High-throughput interaction; "protein binding" is uninformative and no functional
module is established. Retained (experimental IPI) but marked over-annotated.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Q01433; Q9BW71: HIRIP3"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:34819669
qualifier: enables
review:
summary: >-
IntAct IPI reporting an interaction with HIRIP3 (Q9BW71) from a multi-scale cell-structure
map (AP-MS/imaging). Uninformative bare protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: >-
High-throughput interaction; "protein binding" is uninformative and no functional
module is established. Retained (experimental IPI) but marked over-annotated.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Q01433; Q9BW71: HIRIP3"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:40205054
qualifier: enables
review:
summary: >-
IntAct IPI reporting an interaction with HIRIP3 (Q9BW71) from a multimodal cell-map
study. Uninformative bare protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: >-
High-throughput interaction; "protein binding" is uninformative and no functional
module is established. Retained (experimental IPI) but marked over-annotated.
supported_by:
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Q01433; Q9BW71: HIRIP3"
- term:
id: GO:0046033
label: AMP metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Ensembl orthology-based electronic transfer (from mouse Ampd2, Q9DBT5) of AMP metabolic
process. Correct, and redundant with the IBA annotation of the same term.
action: ACCEPT
reason: >-
AMP is the substrate of AMPD2; this is a correct core process annotation.
supported_by:
- reference_id: PMID:23911318
supporting_text: AMPD2 executes AMP deamination
- term:
id: GO:0046034
label: ATP metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Ensembl orthology-based electronic annotation (from mouse Q9DBT5). AMPD2 loss elevates
ATP levels, so its activity indirectly influences ATP/adenylate pools, but ATP is
neither substrate nor product of the deaminase reaction.
action: KEEP_AS_NON_CORE
reason: >-
Biologically supported as an indirect/regulatory effect (AMPD2-deficient cells accumulate
ATP), not the direct catalyzed reaction. Retained as non-core.
supported_by:
- reference_id: PMID:23911318
supporting_text: elevated ATP levels, more striking in AMPD2 homozygous mutant cells
- term:
id: GO:0046039
label: GTP metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Ensembl orthology-based electronic annotation (from mouse Q9DBT5). AMPD2 activity is
required to sustain the guanine nucleotide (GTP) pool by relieving feedback inhibition
of de novo purine synthesis; AMPD2 loss depletes GTP. This is an indirect/regulatory
role rather than the direct catalyzed reaction.
action: KEEP_AS_NON_CORE
reason: >-
Strongly supported biologically as a downstream consequence of AMPD2 activity (GTP
halved in patient neural progenitors), but AMPD2 does not directly metabolize GTP.
Retained as an important non-core process.
supported_by:
- reference_id: PMID:23911318
supporting_text: dramatic reduction in guanine nucleotides, most remarkable for GTP, which was reduced by half
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-76590
qualifier: located_in
review:
summary: >-
Cytosolic localization of AMP deaminase, asserted by Reactome. Consistent with the
known subcellular distribution of the enzyme.
action: ACCEPT
reason: >-
AMPD is a cytosolic enzyme; the localization is well established and appropriate as the
core cellular component.
supported_by:
- reference_id: Reactome:R-HSA-76590
supporting_text: Cytosolic AMP deaminase (AMPD) catalyzes the hydrolysis of AMP to yield IMP and ammonia
- term:
id: GO:0032263
label: GMP salvage
evidence_type: IDA
original_reference_id: PMID:29079593
qualifier: acts_upstream_of_or_within
review:
summary: >-
MGI IDA to GMP salvage citing a red-blood-cell purine-metabolism study. That study
centers on the erythrocyte AMPD isoform (AMPD3) and the RBC purine salvage/deamination
network; it does not establish AMPD2 specifically in GMP salvage, and mechanistically
AMP deaminase produces IMP (not GMP).
action: MARK_AS_OVER_ANNOTATED
reason: >-
The term is a poor fit for AMP deaminase (which acts on AMP->IMP, upstream of, but not
within, GMP salvage), and the cited paper foregrounds the erythrocyte AMPD3 isoform and
the salvage network generally. Per curation policy this experimental annotation is not
removed; the loose acts_upstream_of_or_within qualifier is retained but marked as an
over-annotation for AMPD2.
supported_by:
- reference_id: PMID:29079593
supporting_text: enhanced purine salvage reactions in human and mouse red blood cells
- term:
id: GO:0052652
label: cyclic purine nucleotide metabolic process
evidence_type: IMP
original_reference_id: PMID:23911318
qualifier: involved_in
review:
summary: >-
IMP annotation from the AMPD2/PCH9 study. That work demonstrates AMPD2's role in
purine (AMP/IMP/GTP) nucleotide metabolism and guanine-nucleotide homeostasis, not in
cyclic nucleotide (cAMP/cGMP) metabolism specifically, so the chosen term is a mismatch
to the experimental readouts.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The phenotype (guanine/adenine nucleotide pool changes, translation initiation defect)
supports purine-nucleotide metabolic terms rather than "cyclic purine nucleotide
metabolic process". Experimental annotation, so not removed; marked over-annotated as
the AMP/IMP/purine metabolic process terms better capture the finding.
proposed_replacement_terms:
- id: GO:0046033
label: AMP metabolic process
supported_by:
- reference_id: PMID:23911318
supporting_text: we identify AMPD2 as necessary for guanine nucleotide biosynthesis and protein translation
- term:
id: GO:0003876
label: AMP deaminase activity
evidence_type: IGI
original_reference_id: PMID:23911318
qualifier: enables
review:
summary: >-
Experimental (IGI) support for AMP deaminase activity: human AMPD2 functionally
complements the yeast amd1 (AMP deaminase) mutant, and patient cells lacking AMPD2 lose
80-90% of AMP deaminase activity. Core molecular function.
action: ACCEPT
reason: >-
Directly demonstrates AMP deaminase activity for AMPD2 via cross-species genetic
interaction/complementation and enzymatic assay of patient cells. This is the core
function.
supported_by:
- reference_id: PMID:23911318
supporting_text: which converts AMP to IMP
- term:
id: GO:0006188
label: IMP biosynthetic process
evidence_type: IGI
original_reference_id: PMID:23911318
qualifier: acts_upstream_of_or_within
review:
summary: >-
Experimental (IGI, yeast amd1 complementation) support that AMPD2 acts in production of
IMP from AMP. Consistent with the core metabolic role of the enzyme.
action: ACCEPT
reason: >-
Supported by functional complementation and by the direct chemistry of the reaction
(AMP->IMP). Correct process for the gene.
supported_by:
- reference_id: PMID:23911318
supporting_text: which converts AMP to IMP
- term:
id: GO:0097009
label: energy homeostasis
evidence_type: IGI
original_reference_id: PMID:23911318
qualifier: acts_upstream_of_or_within
review:
summary: >-
Experimental (IGI) support linking AMPD2 to cellular energy/purine homeostasis via the
yeast amd1 complementation system and the demonstrated regulation of adenine/guanine
nucleotide pools. A valid higher-level physiological role.
action: KEEP_AS_NON_CORE
reason: >-
Downstream physiological role (setting the adenylate energy charge / purine pools)
rather than the direct catalytic activity; retained as non-core.
supported_by:
- reference_id: PMID:23911318
supporting_text: essential for cellular energy homeostasis and nucleic acid synthesis
- term:
id: GO:0003876
label: AMP deaminase activity
evidence_type: NAS
original_reference_id: PMID:8764830
qualifier: enables
review:
summary: >-
Author statement (NAS) of AMP deaminase activity from the AMPD2 gene cloning and
characterization paper, which describes AMPD2 as a member of the AMP deaminase multigene
family. Same core function as the IBA/IGI/IEA annotations.
action: ACCEPT
reason: >-
Correct core molecular function; the cloning paper explicitly identifies AMPD2 as an AMP
deaminase family gene. Redundant with stronger experimental evidence but accurate.
supported_by:
- reference_id: PMID:8764830
supporting_text: "AMP deaminase (AMPD) is manifest through a multigene family in higher"
- term:
id: GO:0006196
label: AMP catabolic process
evidence_type: IDA
original_reference_id: PMID:23911318
qualifier: involved_in
review:
summary: >-
Proposed annotation for the most precise process term describing the AMPD2 reaction:
catabolic breakdown of AMP (AMP -> IMP + ammonia). Directly supported by the
demonstrated AMP deaminase activity and loss of that activity in patient cells.
action: NEW
reason: >-
The AMP->IMP deamination is a breakdown of AMP and is best captured by AMP catabolic
process. Existing annotations use the broader parent (AMP metabolic process, GO:0046033)
and product-oriented terms (IMP biosynthetic process); adding the specific catabolic
term makes the substrate-consuming role explicit. Supported experimentally.
supported_by:
- reference_id: PMID:23911318
supporting_text: which converts AMP to IMP
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Catalyzes the deamination of AMP to IMP and plays an important role in"
core_functions:
- description: >-
Cytosolic zinc-dependent hydrolytic deamination of AMP to IMP and ammonia, the committed
step of the purine nucleotide cycle and AMP catabolism.
molecular_function:
id: GO:0003876
label: AMP deaminase activity
directly_involved_in:
- id: GO:0006196
label: AMP catabolic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:23911318
supporting_text: which converts AMP to IMP
- reference_id: file:human/AMPD2/AMPD2-uniprot.txt
supporting_text: "Catalyzes the deamination of AMP to IMP and plays an important role in"
- description: >-
Regulation of adenine/guanine nucleotide pools and the adenylate energy charge: by
deaminating AMP, AMPD2 relieves feedback inhibition of de novo purine synthesis and thereby
sustains the guanine nucleotide (GTP) pool, important for GTP-dependent translation in neurons.
molecular_function:
id: GO:0003876
label: AMP deaminase activity
directly_involved_in:
- id: GO:0046033
label: AMP metabolic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:23911318
supporting_text: we identify AMPD2 as necessary for guanine nucleotide biosynthesis and protein translation
- reference_id: PMID:23911318
supporting_text: dramatic reduction in guanine nucleotides, most remarkable for GTP, which was reduced by half
proposed_new_terms: []
suggested_questions:
- question: >-
Do the four AMPD2 splice isoforms (differing mainly in N-terminal extension) differ in
catalytic regulation, subcellular targeting, or tissue distribution?
- question: >-
In post-mitotic neurons, where de novo purine synthesis is low, what is the precise
mechanism by which AMPD2 loss depletes GTP and impairs translation initiation?
suggested_experiments:
- description: >-
Isoform-resolved enzyme kinetics and allosteric regulation (by ATP, GTP, phosphate) of the
four AMPD2 splice variants expressed and purified in parallel.
- description: >-
Metabolic-flux (labeled-adenosine) analysis in AMPD2-null vs rescued human neurons to map
how the AMP->IMP block redistributes purine flux toward or away from the guanine branch.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:21044950
title: Genome-wide YFP fluorescence complementation screen identifies new regulators
for telomere signaling in human cells.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
High-throughput telomere-signaling complementation screen; source of a binary AMPD2-TERF1
interaction reported to IntAct. Does not establish a physiological AMPD2 function.
- id: PMID:23911318
title: AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative
brainstem disorder.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Definitive functional paper: establishes AMPD2 (AMP->IMP) as required for guanine
nucleotide/GTP homeostasis and translation, and identifies loss-of-function mutations as
the cause of PCH9. Full text available and directly supports the core function.
- id: PMID:25416956
title: A proteome-scale map of the human interactome network.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Proteome-scale Y2H interactome; source of an AMPD2-CCNDBP1 interaction in IntAct.
Background interactome data, not a functional characterization of AMPD2.
- id: PMID:29079593
title: Hypoxia modulates the purine salvage pathway and decreases red blood cell
and supernatant levels of hypoxanthine during refrigerated storage.
findings: []
reference_review:
relevance: LOW
correctness: MISCITED
review_notes: >-
Study of erythrocyte purine metabolism centered on the RBC AMPD isoform (AMPD3) and the
salvage/deamination network; cited for an AMPD2 GMP salvage IDA, but it does not establish
AMPD2 in GMP salvage (AMP deaminase makes IMP, not GMP).
- id: PMID:31515488
title: Extensive disruption of protein interactions by genetic variants across the
allele frequency spectrum in human populations.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Variant/interactome study; source of an AMPD2-CCNDBP1 interaction in IntAct. Background
interactome data.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
BioPlex proteome-scale AP-MS interactome; source of an AMPD2-HIRIP3 interaction in IntAct.
- id: PMID:34819669
title: A multi-scale map of cell structure fusing protein images and interactions.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Multi-scale cell-structure map; source of an AMPD2-HIRIP3 interaction in IntAct.
- id: PMID:40205054
title: Multimodal cell maps as a foundation for structural and functional genomics.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Multimodal cell-map study; source of an AMPD2-HIRIP3 interaction in IntAct.
- id: PMID:8764830
title: 'Cloning, sequence and characterization of the human AMPD2 gene: evidence
for transcriptional regulation by two closely spaced promoters.'
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Original AMPD2 gene cloning/characterization; identifies AMPD2 as a member of the AMP
deaminase multigene family (basis of the NAS AMP deaminase activity annotation).
Abstract-only in cache.
- id: Reactome:R-HSA-76590
title: AMP + H2O => IMP + NH4+ (AMPD)
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Reactome reaction for cytosolic AMP deaminase (AMP -> IMP + ammonia); basis of the cytosol
TAS localization and consistent with the core catalytic function.
- id: file:human/AMPD2/AMPD2-uniprot.txt
title: UniProtKB entry Q01433 (AMPD2_HUMAN)
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
UniProt record providing catalytic activity (EC 3.5.4.6; AMP + H2O + H+ = IMP + NH4+),
zinc cofactor, homotetramer, cytosolic IMP-salvage pathway assignment, tissue specificity,
interaction partners, and PCH9/SPG63 disease associations.